Gossamer Bio, Inc. (GOSS) vs MindWalk Holdings Corp. (HYFT)

Gossamer Bio, Inc. and MindWalk Holdings Corp. are both Biotechnology companies. Gossamer Bio, Inc. and MindWalk Holdings Corp. are of similar size ($66.9M and $66.8M). Gossamer Bio, Inc. grew revenue faster over the last twelve months: 32.4% against −27.0%. MindWalk Holdings Corp. has the higher net margin (−105.1% vs −235.0%) and the lower return on invested capital (−464.6% vs 0.00%). Across the 16 metrics below, Gossamer Bio, Inc. leads on 8 and MindWalk Holdings Corp. on 8.

Valuation

Metric GOSS HYFT Biotechnology median
P/E n/m n/m 7.88
P/S 0.82 5.51 11.47
P/B n/m 13.05 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 4.16 5.42 10.73
Earnings yield (416.82%) (19.07%) (28.84%)
Free cash flow yield (371.79%) (13.93%) (23.03%)

Profitability

Metric GOSS HYFT Biotechnology median
Gross margin 100.00% 60.81% 65.16%
Operating margin (311.70%) (103.99%) 0.00%
Net margin (235.00%) (105.06%) 0.00%
Free cash flow margin (305.19%) (76.79%) 0.00%
Return on equity 178.72% (122.85%) (57.72%)
Return on assets (78.81%) (58.55%) (49.22%)
Return on invested capital 0.00% (464.59%) 0.00%

Growth

Metric GOSS HYFT Biotechnology median
Revenue growth (TTM) 32.43% (26.99%) 5.64%
EPS growth (last fiscal year) (200.00%) 66.15% —
Revenue growth, 5-year CAGR — (3.83%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GOSS HYFT Biotechnology median
Debt to equity (0.38) 0.43 0.00
Current ratio 0.53 1.84 4.73
Net debt to EBITDA (0.35) 0.62 0.96

Dividend

Metric GOSS HYFT Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric GOSS HYFT Biotechnology median
Market cap 66.79m 66.90m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack